145 related articles for article (PubMed ID: 24274563)
1. Synthesis and characterization of biotin modified cholesteryl pullulan as a novel anticancer drug carrier.
Yang W; Wang M; Ma L; Li H; Huang L
Carbohydr Polym; 2014 Jan; 99():720-7. PubMed ID: 24274563
[TBL] [Abstract][Full Text] [Related]
2. The preliminary evaluation on cholesterol-modified pullulan as a drug nanocarrier.
Shen S; Li H; Yang W
Drug Deliv; 2014 Nov; 21(7):501-8. PubMed ID: 24625263
[TBL] [Abstract][Full Text] [Related]
3. Self-aggregated nanoparticles from methoxy poly(ethylene glycol)-modified chitosan: synthesis; characterization; aggregation and methotrexate release in vitro.
Yang X; Zhang Q; Wang Y; Chen H; Zhang H; Gao F; Liu L
Colloids Surf B Biointerfaces; 2008 Feb; 61(2):125-31. PubMed ID: 17869489
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of stearic acid-pullulan nanoparticles.
Kim IS; Oh IJ
Arch Pharm Res; 2010 May; 33(5):761-7. PubMed ID: 20512475
[TBL] [Abstract][Full Text] [Related]
5. Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy.
Zhang HZ; Gao FP; Liu LR; Li XM; Zhou ZM; Yang XD; Zhang QQ
Colloids Surf B Biointerfaces; 2009 Jun; 71(1):19-26. PubMed ID: 19186037
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of Biotin-Modified Galactosylated Chitosan Nanoparticles and Their Characteristics in Vitro and in Vivo.
Cheng M; Ma D; Zhi K; Liu B; Zhu W
Cell Physiol Biochem; 2018; 50(2):569-584. PubMed ID: 30308481
[TBL] [Abstract][Full Text] [Related]
7. Stability and in vivo evaluation of pullulan acetate as a drug nanocarrier.
Tang HB; Li L; Chen H; Zhou ZM; Chen HL; Li XM; Liu LR; Wang YS; Zhang QQ
Drug Deliv; 2010; 17(7):552-8. PubMed ID: 20550433
[TBL] [Abstract][Full Text] [Related]
8. Preparation of folate-modified pullulan acetate nanoparticles for tumor-targeted drug delivery.
Zhang HZ; Li XM; Gao FP; Liu LR; Zhou ZM; Zhang QQ
Drug Deliv; 2010 Jan; 17(1):48-57. PubMed ID: 22747075
[TBL] [Abstract][Full Text] [Related]
9. Glycyrrhetinic acid-cyclodextrin grafted pullulan nanoparticles loaded doxorubicin as a liver targeted delivery carrier.
Yang W; Zhang Y; Wang J; Li H; Yang H
Int J Biol Macromol; 2022 Sep; 216():789-798. PubMed ID: 35914549
[TBL] [Abstract][Full Text] [Related]
10. Self-assembled nanoparticles of cholesterol-conjugated carboxymethyl curdlan as a novel carrier of epirubicin.
Li L; Gao FP; Tang HB; Bai YG; Li RF; Li XM; Liu LR; Wang YS; Zhang QQ
Nanotechnology; 2010 Jul; 21(26):265601. PubMed ID: 20522924
[TBL] [Abstract][Full Text] [Related]
11. Effect of pullulan nanoparticle surface charges on HSA complexation and drug release behavior of HSA-bound nanoparticles.
Tao X; Zhang Q; Ling K; Chen Y; Yang W; Gao F; Shi G
PLoS One; 2012; 7(11):e49304. PubMed ID: 23166632
[TBL] [Abstract][Full Text] [Related]
12. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
13. New method and characterization of self-assembled gelatin-oleic nanoparticles using a desolvation method via carbodiimide/N-hydroxysuccinimide (EDC/NHS) reaction.
Park C; Vo CL; Kang T; Oh E; Lee BJ
Eur J Pharm Biopharm; 2015 Jan; 89():365-73. PubMed ID: 25536111
[TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of doxorubicin to liver used a novel biotinylated β-cyclodextrin grafted pullulan nanocarrier.
Yang W; Xue Y; Cui X; Tang H; Li H
Colloids Surf B Biointerfaces; 2022 Dec; 220():112934. PubMed ID: 36265313
[TBL] [Abstract][Full Text] [Related]
15. Pullulan-based nanoparticles as carriers for transmucosal protein delivery.
Dionísio M; Cordeiro C; Remuñán-López C; Seijo B; Rosa da Costa AM; Grenha A
Eur J Pharm Sci; 2013 Sep; 50(1):102-13. PubMed ID: 23624352
[TBL] [Abstract][Full Text] [Related]
16. Cellular uptake mechanism and intracellular fate of hydrophobically modified pullulan nanoparticles.
Jiang L; Li X; Liu L; Zhang Q
Int J Nanomedicine; 2013; 8():1825-34. PubMed ID: 23674894
[TBL] [Abstract][Full Text] [Related]
17. Poly(ester anhydride)/mPEG amphiphilic block co-polymer nanoparticles as delivery devices for paclitaxel.
Liang Y; Xiao L; Li Y; Zhai Y; Xie C; Deng L; Dong A
J Biomater Sci Polym Ed; 2011; 22(4-6):701-15. PubMed ID: 20566053
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
[TBL] [Abstract][Full Text] [Related]
19. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
Garg A; Singh S
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, release kinetics and toxicity profile of drug-loaded starch nanoparticles.
El-Naggar ME; El-Rafie MH; El-sheikh MA; El-Feky GS; Hebeish A
Int J Biol Macromol; 2015 Nov; 81():718-29. PubMed ID: 26358550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]